Lawmakers Seo Mi-hwa, Kim Hyeong-dong and MFDS Hold Policy Forum on Introducing Cannabis-Derived Medicines — Call for Domestic CBD Production Raised

Lawmakers Seo Mi-hwa and Kim Hyeong-dong and the Ministry of Food and Drug Safety (MFDS) jointly held a policy forum on July 7 at the National Assembly Members' Office Building to discuss measures for introducing cannabis-derived medicines. Experts agreed that establishing a domestic production and supply system for medical CBD (Epidiolex) is necessary to expand treatment opportunities for patients with drug‑resistant epilepsy. They highlighted the limitations of the current model, which relies entirely on imports, and criticized the complex administrative procedures. The Korean traditional medicine sector urged preparation of a development base for cannabis-containing herbal formulations. The MFDS said it would engage in the legislative process provided strict safety controls are ensured.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.